Fujishima, H.; Okada, N.; Matsumoto, K.; Shimizu, E.; Fukuda, S.; Tomita, M.
Conjunctival Injection Reduction in Patients with Atopic Keratoconjunctivitis Due to Synergic Effect of Bovine Enteric-Coated Lactoferrin in 0.1% Tacrolimus Ophthalmic Suspension. J. Clin. Med. 2020, 9, 3093.
https://doi.org/10.3390/jcm9103093
AMA Style
Fujishima H, Okada N, Matsumoto K, Shimizu E, Fukuda S, Tomita M.
Conjunctival Injection Reduction in Patients with Atopic Keratoconjunctivitis Due to Synergic Effect of Bovine Enteric-Coated Lactoferrin in 0.1% Tacrolimus Ophthalmic Suspension. Journal of Clinical Medicine. 2020; 9(10):3093.
https://doi.org/10.3390/jcm9103093
Chicago/Turabian Style
Fujishima, Hiroshi, Naoko Okada, Kenji Matsumoto, Eisuke Shimizu, Shinji Fukuda, and Masaru Tomita.
2020. "Conjunctival Injection Reduction in Patients with Atopic Keratoconjunctivitis Due to Synergic Effect of Bovine Enteric-Coated Lactoferrin in 0.1% Tacrolimus Ophthalmic Suspension" Journal of Clinical Medicine 9, no. 10: 3093.
https://doi.org/10.3390/jcm9103093
APA Style
Fujishima, H., Okada, N., Matsumoto, K., Shimizu, E., Fukuda, S., & Tomita, M.
(2020). Conjunctival Injection Reduction in Patients with Atopic Keratoconjunctivitis Due to Synergic Effect of Bovine Enteric-Coated Lactoferrin in 0.1% Tacrolimus Ophthalmic Suspension. Journal of Clinical Medicine, 9(10), 3093.
https://doi.org/10.3390/jcm9103093
